{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:32:26Z","timestamp":1787614346662,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work is supported by the Alzheimer\u2019s disease Research Program startup fund to Dr. Sharoar from the Corewell Health East (formally Beaumont Health)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-024-03930-7","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T09:21:41Z","timestamp":1731576101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Highly prevalent geriatric medications and their effect on \u03b2-amyloid fibril formation"],"prefix":"10.1186","volume":"24","author":[{"given":"Zakia","family":"Zaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radia","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavya","family":"Koganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhavkumar","family":"Falki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Osentoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Golam","family":"Sharoar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"issue":"2","key":"3930_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/ageing\/afu189","volume":"44","author":"M Sander","year":"2015","unstructured":"Sander M, Oxlund B, Jespersen A, Krasnik A, Mortensen EL, Westendorp RG, Rasmussen LJ. <ArticleTitle Language=\u201cEn\u201d>The challenges of human population ageing. Age Ageing. 2015;44(2):185\u20137.","journal-title":"Age Ageing"},{"issue":"28","key":"3930_CR2","doi-asserted-by":"publisher","first-page":"604","DOI":"10.46234\/ccdcw2021.160","volume":"3","author":"D Gu","year":"2021","unstructured":"Gu D, Andreev K, Dupre ME. Major Trends in Population Growth Around the World. China CDC Wkly. 2021;3(28):604\u201313.","journal-title":"China CDC Wkly"},{"key":"3930_CR3","doi-asserted-by":"crossref","unstructured":"2023 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 2023, 19(4):1598\u20131695.","DOI":"10.1002\/alz.13016"},{"key":"3930_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fpubh.2017.00335","volume":"5","author":"E Jaul","year":"2017","unstructured":"Jaul E, Barron J. Age-Related Diseases and Clinical and Public Health Implications for the 85 Years Old and Over Population. Front Public Health. 2017;5:335.","journal-title":"Front Public Health"},{"issue":"1","key":"3930_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12877-021-02217-7","volume":"21","author":"J Barrio-Cortes","year":"2021","unstructured":"Barrio-Cortes J, Castano-Reguillo A, Beca-Martinez MT, Bandeira-de Oliveira M, Lopez-Rodriguez C, Jaime-Siso MA. Chronic diseases in the geriatric population: morbidity and use of primary care services according to risk level. BMC Geriatr. 2021;21(1):278.","journal-title":"BMC Geriatr"},{"issue":"3","key":"3930_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s40471-021-00274-5","volume":"8","author":"HE Barry","year":"2021","unstructured":"Barry HE, Hughes CM. An Update on Medication Use in Older Adults: a Narrative Review. Curr Epidemiol Rep. 2021;8(3):108\u201315.","journal-title":"Curr Epidemiol Rep"},{"issue":"12","key":"3930_CR7","first-page":"992","volume":"13","author":"M Ayan","year":"2016","unstructured":"Ayan M, Pothineni NV, Siraj A, Mehta JL. Cardiac drug therapy-considerations in the elderly. J Geriatr Cardiol. 2016;13(12):992\u20137.","journal-title":"J Geriatr Cardiol"},{"issue":"6","key":"3930_CR8","first-page":"i","volume":"6","author":"RJ Dagli","year":"2014","unstructured":"Dagli RJ, Sharma A. Polypharmacy: a global risk factor for elderly people. J Int Oral Health. 2014;6(6):i\u2013ii.","journal-title":"J Int Oral Health"},{"issue":"9","key":"3930_CR9","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1111\/jgs.17291","volume":"69","author":"ME Growdon","year":"2021","unstructured":"Growdon ME, Gan S, Yaffe K, Steinman MA. Polypharmacy among older adults with dementia compared with those without dementia in the United States. J Am Geriatr Soc. 2021;69(9):2464\u201375.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"3930_CR10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.cger.2013.07.002","volume":"29","author":"CN Harada","year":"2013","unstructured":"Harada CN, Natelson Love MC, Triebel KL. Normal cognitive aging. Clin Geriatr Med. 2013;29(4):737\u201352.","journal-title":"Clin Geriatr Med"},{"issue":"3","key":"3930_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-0035-1555115","volume":"36","author":"DL Murman","year":"2015","unstructured":"Murman DL. The Impact of Age on Cognition. Semin Hear. 2015;36(3):111\u201321.","journal-title":"Semin Hear"},{"issue":"17","key":"3930_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.21037\/atm.2018.08.04","volume":"6","author":"GM Sancesario","year":"2018","unstructured":"Sancesario GM, Bernardini S. Diagnosis of neurodegenerative dementia: where do we stand, now? Ann Transl Med. 2018;6(17):340.","journal-title":"Ann Transl Med"},{"issue":"2","key":"3930_CR13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell. 2019;179(2):312\u201339.","journal-title":"Cell"},{"issue":"5580","key":"3930_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353\u20136.","journal-title":"Science"},{"issue":"5054","key":"3930_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science"},{"issue":"5","key":"3930_CR16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/BF00296107","volume":"79","author":"DW Dickson","year":"1990","unstructured":"Dickson DW, Wertkin A, Mattiace LA, Fier E, Kress Y, Davies P, Yen SH. Ubiquitin immunoelectron microscopy of dystrophic neurites in cerebellar senile plaques of Alzheimer\u2019s disease. Acta Neuropathol. 1990;79(5):486\u201393.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3930_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/exnr.1998.7010","volume":"156","author":"TC Dickson","year":"1999","unstructured":"Dickson TC, King CE, McCormack GH, Vickers JC. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer\u2019s disease. Exp Neurol. 1999;156(1):100\u201310.","journal-title":"Exp Neurol"},{"issue":"3\u20134","key":"3930_CR18","first-page":"279","volume":"89","author":"MB Lenders","year":"1989","unstructured":"Lenders MB, Peers MC, Tramu G, Delacourte A, Defossez A, Petit H, Mazzuca M. Dystrophic neuropeptidergic neurites in senile plaques of Alzheimer\u2019s disease precede formation of paired helical filaments. Acta Neurol Belg. 1989;89(3\u20134):279\u201385.","journal-title":"Acta Neurol Belg"},{"key":"3930_CR19","doi-asserted-by":"crossref","unstructured":"Sharoar MG, Hu X, Ma XM, Zhu X, Yan R. Sequential formation of different layers of dystrophic neurites in Alzheimer\u2019s brains. Mol Psychiatry 2019.","DOI":"10.1038\/s41380-019-0396-2"},{"key":"3930_CR20","doi-asserted-by":"crossref","unstructured":"Sharoar MG, Shi Q, Ge Y, He W, Hu X, Perry G, Zhu X, Yan R. Dysfunctional tubular endoplasmic reticulum constitutes a pathological feature of Alzheimer\u2019s disease. Mol Psychiatry 2015.","DOI":"10.1038\/mp.2015.181"},{"issue":"Pt 23","key":"3930_CR21","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1242\/jcs.019265","volume":"120","author":"RA Nixon","year":"2007","unstructured":"Nixon RA. Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci. 2007;120(Pt 23):4081\u201391.","journal-title":"J Cell Sci"},{"issue":"7","key":"3930_CR22","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1096\/fj.201700359","volume":"31","author":"RA Nixon","year":"2017","unstructured":"Nixon RA. Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer\u2019s disease: inseparable partners in a multifactorial disease. Faseb j. 2017;31(7):2729\u201343.","journal-title":"Faseb j"},{"issue":"2","key":"3930_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","volume":"64","author":"RA Nixon","year":"2005","unstructured":"Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, Cuervo AM. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol. 2005;64(2):113\u201322.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3930_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbr.2016.05.030","volume":"311","author":"EJ Mufson","year":"2016","unstructured":"Mufson EJ, Ikonomovic MD, Counts SE, Perez SE, Malek-Ahmadi M, Scheff SW, Ginsberg SD. Molecular and cellular pathophysiology of preclinical Alzheimer\u2019s disease. Behav Brain Res. 2016;311:54\u201369.","journal-title":"Behav Brain Res"},{"issue":"2","key":"3930_CR25","doi-asserted-by":"publisher","first-page":"e12385","DOI":"10.1002\/trc2.12385","volume":"9","author":"J Cummings","year":"2023","unstructured":"Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F. Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimers Dement (N Y). 2023;9(2):e12385.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"3930_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.719","volume":"8","author":"J Bieschke","year":"2011","unstructured":"Bieschke J, Herbst M, Wiglenda T, Friedrich RP, Boeddrich A, Schiele F, Kleckers D, Lopez del Amo JM, Gruning BA, Wang Q, et al. Small-molecule conversion of toxic oligomers to nontoxic beta-sheet-rich amyloid fibrils. Nat Chem Biol. 2011;8(1):93\u2013101.","journal-title":"Nat Chem Biol"},{"key":"3930_CR27","doi-asserted-by":"crossref","unstructured":"Lieblein T, Zangl R, Martin J, Hoffmann J, Hutchison MJ, Stark T, Stirnal E, Schrader T, Schwalbe H, Morgner N. Structural rearrangement of amyloid-beta upon inhibitor binding suppresses formation of Alzheimer\u2019s disease related oligomers. Elife 2020, 9.","DOI":"10.7554\/eLife.59306"},{"issue":"1","key":"3930_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.abb.2013.08.004","volume":"538","author":"MG Sharoar","year":"2013","unstructured":"Sharoar MG, Shahnawaz M, Islam MI, Ramasamy VS, Shin SY, Park IS. The inhibitory effects of Escherichia coli maltose binding protein on beta-amyloid aggregation and cytotoxicity. Arch Biochem Biophys. 2013;538(1):41\u20138.","journal-title":"Arch Biochem Biophys"},{"key":"3930_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1423-0127-19-104","volume":"19","author":"MG Sharoar","year":"2012","unstructured":"Sharoar MG, Thapa A, Shahnawaz M, Ramasamy VS, Woo ER, Shin SY, Park IS. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates. J Biomed Sci. 2012;19:104.","journal-title":"J Biomed Sci"},{"issue":"13","key":"3930_CR30","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1021\/bi101731d","volume":"50","author":"A Thapa","year":"2011","unstructured":"Thapa A, Woo ER, Chi EY, Sharoar MG, Jin HG, Shin SY, Park IS. Biflavonoids are superior to monoflavonoids in inhibiting amyloid-beta toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures. Biochemistry. 2011;50(13):2445\u201355.","journal-title":"Biochemistry"},{"issue":"7","key":"3930_CR31","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34(7):939\u201344.","journal-title":"Neurology"},{"issue":"8","key":"3930_CR32","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/gerona\/glv013","volume":"70","author":"CJ Charlesworth","year":"2015","unstructured":"Charlesworth CJ, Smit E, Lee DS, Alramadhan F, Odden MC. Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988\u20132010. J Gerontol Biol Sci Med Sci. 2015;70(8):989\u201395.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"3930_CR33","doi-asserted-by":"crossref","unstructured":"Esumi S, Ushio S, Zamami Y. Polypharmacy in Older Adults with Alzheimer\u2019s Disease. Med (Kaunas) 2022, 58(10).","DOI":"10.3390\/medicina58101445"},{"issue":"1","key":"3930_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/2042098616670798","volume":"8","author":"C Parsons","year":"2017","unstructured":"Parsons C. Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem. Ther Adv Drug Saf. 2017;8(1):31\u201346.","journal-title":"Ther Adv Drug Saf"},{"issue":"35","key":"3930_CR35","doi-asserted-by":"publisher","first-page":"14745","DOI":"10.1073\/pnas.0905127106","volume":"106","author":"K Ono","year":"2009","unstructured":"Ono K, Condron MM, Teplow DB. Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc Natl Acad Sci U S A. 2009;106(35):14745\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3930_CR36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1006\/taap.1993.1108","volume":"120","author":"B Veronesi","year":"1993","unstructured":"Veronesi B, Ehrich M. Differential cytotoxic sensitivity in mouse and human cell lines exposed to organophosphate insecticides. Toxicol Appl Pharmacol. 1993;120(2):240\u20136.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"15","key":"3930_CR37","doi-asserted-by":"publisher","first-page":"7942","DOI":"10.1073\/pnas.94.15.7942","volume":"94","author":"A Lomakin","year":"1997","unstructured":"Lomakin A, Teplow DB, Kirschner DA, Benedek GB. Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci U S A. 1997;94(15):7942\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9836","key":"3930_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(12)60482-6","volume":"380","author":"C Salisbury","year":"2012","unstructured":"Salisbury C. Multimorbidity: redesigning health care for people who use it. Lancet. 2012;380(9836):7\u20139.","journal-title":"Lancet"},{"issue":"12","key":"3930_CR39","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1111\/jgs.13153","volume":"62","author":"TR Fried","year":"2014","unstructured":"Fried TR, O\u2019Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62(12):2261\u201372.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"3930_CR40","first-page":"33","volume":"46","author":"F Clague","year":"2017","unstructured":"Clague F, Mercer SW, McLean G, Reynish E, Guthrie B. Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data. Age Ageing. 2017;46(1):33\u20139.","journal-title":"Age Ageing"},{"issue":"7","key":"3930_CR41","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jamda.2017.02.009","volume":"18","author":"N Veronese","year":"2017","unstructured":"Veronese N, Stubbs B, Noale M, Solmi M, Pilotto A, Vaona A, Demurtas J, Mueller C, Huntley J, Crepaldi G, et al. Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study. J Am Med Dir Assoc. 2017;18(7):624\u20138.","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"3930_CR42","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/jgs.15774","volume":"67","author":"M Montero-Odasso","year":"2019","unstructured":"Montero-Odasso M, Sarquis-Adamson Y, Song HY, Bray NW, Pieruccini-Faria F, Speechley M. Polypharmacy, Gait Performance, and Falls in Community-Dwelling Older Adults. Results from the Gait and Brain Study. J Am Geriatr Soc. 2019;67(6):1182\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"3930_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.phrs.2016.02.020","volume":"109","author":"CI Ghanem","year":"2016","unstructured":"Ghanem CI, Perez MJ, Manautou JE, Mottino AD. Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity. Pharmacol Res. 2016;109:119\u201331.","journal-title":"Pharmacol Res"},{"issue":"1","key":"3930_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2125.1992.tb04112.x","volume":"34","author":"B Bannwarth","year":"1992","unstructured":"Bannwarth B, Netter P, Lapicque F, Gillet P, Pere P, Boccard E, Royer RJ, Gaucher A. Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol. Br J Clin Pharmacol. 1992;34(1):79\u201381.","journal-title":"Br J Clin Pharmacol"},{"key":"3930_CR45","doi-asserted-by":"crossref","unstructured":"Paul M, Paul JW, Hinwood M, Hood RJ, Martin K, Abdolhoseini M, Johnson SJ, Pollack M, Nilsson M, Walker FR. Clopidogrel Administration Impairs Post-Stroke Learning and Memory Recovery in Mice. Int J Mol Sci 2023, 24(14).","DOI":"10.3390\/ijms241411706"},{"issue":"1","key":"3930_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1291\/hypres.29.49","volume":"29","author":"Y Hirooka","year":"2006","unstructured":"Hirooka Y, Kimura Y, Nozoe M, Sagara Y, Ito K, Sunagawa K. Amlodipine-induced reduction of oxidative stress in the brain is associated with sympatho-inhibitory effects in stroke-prone spontaneously hypertensive rats. Hypertens Res. 2006;29(1):49\u201356.","journal-title":"Hypertens Res"},{"issue":"2\u20133","key":"3930_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ejphar.2011.03.048","volume":"659","author":"C Bachmeier","year":"2011","unstructured":"Bachmeier C, Beaulieu-Abdelahad D, Mullan M, Paris D. Selective dihydropyiridine compounds facilitate the clearance of beta-amyloid across the blood-brain barrier. Eur J Pharmacol. 2011;659(2\u20133):124\u20139.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"3930_CR48","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jalz.2019.04.001","volume":"15","author":"L Vermunt","year":"2019","unstructured":"Vermunt L, Sikkes SAM, van den Hout A, Handels R, Bos I, van der Flier WM, Kern S, Ousset PJ, Maruff P, Skoog I, et al. Duration of preclinical, prodromal, and dementia stages of Alzheimer\u2019s disease in relation to age, sex, and APOE genotype. Alzheimers Dement. 2019;15(7):888\u201398.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3930_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","volume":"67","author":"Y Porat","year":"2006","unstructured":"Porat Y, Abramowitz A, Gazit E. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des. 2006;67(1):27\u201337.","journal-title":"Chem Biol Drug Des"},{"issue":"24","key":"3930_CR50","doi-asserted-by":"publisher","first-page":"9758","DOI":"10.1073\/pnas.1218402110","volume":"110","author":"SI Cohen","year":"2013","unstructured":"Cohen SI, Linse S, Luheshi LM, Hellstrand E, White DA, Rajah L, Otzen DE, Vendruscolo M, Dobson CM, Knowles TP. Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A. 2013;110(24):9758\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3930_CR51","first-page":"259","volume":"9","author":"C Annweiler","year":"2011","unstructured":"Annweiler C, Souberbielle JC, Schott AM, de Decker L, Berrut G, Beauchet O. [Vitamin D in the elderly: 5 points to remember]. Geriatr Psychol Neuropsychiatr Vieil. 2011;9(3):259\u201367.","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"},{"issue":"1","key":"3930_CR52","doi-asserted-by":"publisher","first-page":"16271","DOI":"10.1038\/s41598-021-95850-6","volume":"11","author":"H Bakhtiari-Dovvombaygi","year":"2021","unstructured":"Bakhtiari-Dovvombaygi H, Izadi S, Zare M, Asgari Hassanlouei E, Dinpanah H, Ahmadi-Soleimani SM, Beheshti F. Vitamin D3 administration prevents memory deficit and alteration of biochemical parameters induced by unpredictable chronic mild stress in rats. Sci Rep. 2021;11(1):16271.","journal-title":"Sci Rep"},{"issue":"41","key":"3930_CR53","doi-asserted-by":"publisher","first-page":"E4359","DOI":"10.1073\/pnas.1404477111","volume":"111","author":"CS Latimer","year":"2014","unstructured":"Latimer CS, Brewer LD, Searcy JL, Chen KC, Popovic J, Kraner SD, Thibault O, Blalock EM, Landfield PW, Porter NM. Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats. Proc Natl Acad Sci U S A. 2014;111(41):E4359\u20134366.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3930_CR54","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3233\/JAD-2011-101986","volume":"25","author":"J Yu","year":"2011","unstructured":"Yu J, Gattoni-Celli M, Zhu H, Bhat NR, Sambamurti K, Gattoni-Celli S, Kindy MS. Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AbetaPP transgenic mice. J Alzheimers Dis. 2011;25(2):295\u2013307.","journal-title":"J Alzheimers Dis"},{"key":"3930_CR55","doi-asserted-by":"crossref","unstructured":"Grimm MOW, Thiel A, Lauer AA, Winkler J, Lehmann J, Regner L, Nelke C, Janitschke D, Benoist C, Streidenberger O et al. Vitamin D and Its Analogues Decrease Amyloid-beta (Abeta) Formation and Increase Abeta-Degradation. Int J Mol Sci 2017, 18(12).","DOI":"10.3390\/ijms18122764"},{"issue":"7","key":"3930_CR56","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/alz.12113","volume":"16","author":"R Kumar","year":"2020","unstructured":"Kumar R, Kumar A, Nordberg A, Langstrom B, Darreh-Shori T. Proton pump inhibitors act with unprecedented potencies as inhibitors of the acetylcholine biosynthesizing enzyme-A plausible missing link for their association with incidence of dementia. Alzheimers Dement. 2020;16(7):1031\u201342.","journal-title":"Alzheimers Dement"},{"key":"3930_CR57","doi-asserted-by":"crossref","unstructured":"Shin SH, Park Y, Park MH, Byeon JJ, Lee BI, Choi J, Shin YG. Profiling and Identification of Omeprazole Metabolites in Mouse Brain and Plasma by Isotope Ratio-Monitoring Liquid Chromatography-Mass Spectrometric Method. Life (Basel) 2020, 10(7).","DOI":"10.3390\/life10070115"},{"issue":"8","key":"3930_CR58","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/jgh.13750","volume":"32","author":"R Batchelor","year":"2017","unstructured":"Batchelor R, Gilmartin JF, Kemp W, Hopper I, Liew D. Dementia, cognitive impairment and proton pump inhibitor therapy: A systematic review. J Gastroenterol Hepatol. 2017;32(8):1426\u201335.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"3930_CR59","doi-asserted-by":"publisher","first-page":"e0171006","DOI":"10.1371\/journal.pone.0171006","volume":"12","author":"SY Tai","year":"2017","unstructured":"Tai SY, Chien CY, Wu DC, Lin KD, Ho BL, Chang YH, Chang YP. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan. PLoS ONE. 2017;12(2):e0171006.","journal-title":"PLoS ONE"},{"issue":"5","key":"3930_CR60","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cgh.2018.01.034","volume":"16","author":"M Wod","year":"2018","unstructured":"Wod M, Hallas J, Andersen K, Garcia Rodriguez LA, Christensen K, Gaist D. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline. Clin Gastroenterol Hepatol. 2018;16(5):681\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"3930_CR61","doi-asserted-by":"publisher","first-page":"21046","DOI":"10.1038\/s41598-020-78199-0","volume":"10","author":"F Torres-Bondia","year":"2020","unstructured":"Torres-Bondia F, Dakterzada F, Galvan L, Buti M, Besanson G, Gill E, Buil R, de Batlle J, Pinol-Ripoll G. Proton pump inhibitors and the risk of Alzheimer\u2019s disease and non-Alzheimer\u2019s dementias. Sci Rep. 2020;10(1):21046.","journal-title":"Sci Rep"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03930-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-03930-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03930-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T10:04:08Z","timestamp":1731578648000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03930-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3930"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-03930-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Human Investigation Committee of Corewell Health East (CHE) (formally William Beaumont Hospital), Royal Oak, MI, USA under an approved protocol by the Institutional Review Board (IRB#2017\u2009\u2212\u2009214). The CHE Institutional Review Board is accredited by the Association for the Accreditation of Human Research Protection Programs and complies with Good Clinical Practice Guidelines as defined by the U.S. Food and Drug Administration under the Code of Federal Regulations (21 CFR Parts 50 and 56; 45 CFR Part 46) and International Conference on Harmonization (ICH) Guidelines (Section E6). Written consent was obtained from study participants or their legal representatives prior to obtaining the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"445"}}